Logo image of ALHRG.PA

HERIGE (ALHRG.PA) Stock Fundamental Analysis

EPA:ALHRG - Euronext Paris - Matif - FR0000066540 - Common Stock - Currency: EUR

23.9  -0.3 (-1.24%)

Fundamental Rating

6

Overall ALHRG gets a fundamental rating of 6 out of 10. We evaluated ALHRG against 16 industry peers in the Trading Companies & Distributors industry. ALHRG has an excellent profitability rating, but there are some minor concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on ALHRG. This makes ALHRG very considerable for value investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year ALHRG was profitable.
In the past year ALHRG had a positive cash flow from operations.
Each year in the past 5 years ALHRG has been profitable.
In the past 5 years ALHRG always reported a positive cash flow from operatings.
ALHRG.PA Yearly Net Income VS EBIT VS OCF VS FCFALHRG.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M -20M 30M

1.2 Ratios

ALHRG has a better Return On Assets (6.53%) than 93.75% of its industry peers.
ALHRG's Return On Equity of 14.82% is amongst the best of the industry. ALHRG outperforms 93.75% of its industry peers.
Industry RankSector Rank
ROA 6.53%
ROE 14.82%
ROIC N/A
ROA(3y)3.42%
ROA(5y)2.97%
ROE(3y)12.56%
ROE(5y)10.98%
ROIC(3y)N/A
ROIC(5y)N/A
ALHRG.PA Yearly ROA, ROE, ROICALHRG.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 10 -10 15

1.3 Margins

The Profit Margin of ALHRG (3.41%) is better than 68.75% of its industry peers.
ALHRG's Profit Margin has improved in the last couple of years.
ALHRG's Operating Margin has improved in the last couple of years.
The Gross Margin of ALHRG (43.42%) is better than 93.75% of its industry peers.
In the last couple of years the Gross Margin of ALHRG has grown nicely.
Industry RankSector Rank
OM N/A
PM (TTM) 3.41%
GM 43.42%
OM growth 3Y-0.23%
OM growth 5Y12.98%
PM growth 3Y-14.27%
PM growth 5Y37.8%
GM growth 3Y2.69%
GM growth 5Y2.44%
ALHRG.PA Yearly Profit, Operating, Gross MarginsALHRG.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 20 30 40

6

2. Health

2.1 Basic Checks

ALHRG does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALHRG has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for ALHRG has been reduced compared to 5 years ago.
ALHRG has a better debt/assets ratio than last year.
ALHRG.PA Yearly Shares OutstandingALHRG.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 500K 1M 1.5M 2M 2.5M
ALHRG.PA Yearly Total Debt VS Total AssetsALHRG.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

2.2 Solvency

An Altman-Z score of 3.14 indicates that ALHRG is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.14, ALHRG is in line with its industry, outperforming 56.25% of the companies in the same industry.
The Debt to FCF ratio of ALHRG is 20.35, which is on the high side as it means it would take ALHRG, 20.35 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 20.35, ALHRG perfoms like the industry average, outperforming 56.25% of the companies in the same industry.
ALHRG has a Debt/Equity ratio of 0.70. This is a neutral value indicating ALHRG is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.70, ALHRG is doing worse than 62.50% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 20.35
Altman-Z 3.14
ROIC/WACCN/A
WACC4.73%
ALHRG.PA Yearly LT Debt VS Equity VS FCFALHRG.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 2.39 indicates that ALHRG has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.39, ALHRG belongs to the top of the industry, outperforming 81.25% of the companies in the same industry.
ALHRG has a Quick Ratio of 1.91. This is a normal value and indicates that ALHRG is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.91, ALHRG belongs to the top of the industry, outperforming 81.25% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.39
Quick Ratio 1.91
ALHRG.PA Yearly Current Assets VS Current LiabilitesALHRG.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

4

3. Growth

3.1 Past

ALHRG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 39.12%, which is quite impressive.
ALHRG shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 47.38% yearly.
ALHRG shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -14.27%.
ALHRG shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.67% yearly.
EPS 1Y (TTM)39.12%
EPS 3Y-4.01%
EPS 5Y47.38%
EPS Q2Q%151.61%
Revenue 1Y (TTM)-14.27%
Revenue growth 3Y11.65%
Revenue growth 5Y6.67%
Sales Q2Q%-26.32%

3.2 Future

The Earnings Per Share is expected to grow by 10.34% on average over the next years. This is quite good.
Based on estimates for the next years, ALHRG will show a very negative growth in Revenue. The Revenue will decrease by -16.91% on average per year.
EPS Next Y2.21%
EPS Next 2Y10.34%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.21%
Revenue Next 2YN/A
Revenue Next 3Y-16.91%
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALHRG.PA Yearly Revenue VS EstimatesALHRG.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M
ALHRG.PA Yearly EPS VS EstimatesALHRG.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 -2 4 -4 6 8

8

4. Valuation

4.1 Price/Earnings Ratio

ALHRG is valuated cheaply with a Price/Earnings ratio of 2.83.
ALHRG's Price/Earnings ratio is rather cheap when compared to the industry. ALHRG is cheaper than 100.00% of the companies in the same industry.
ALHRG is valuated cheaply when we compare the Price/Earnings ratio to 29.35, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 2.86 indicates a rather cheap valuation of ALHRG.
Based on the Price/Forward Earnings ratio, ALHRG is valued cheaper than 100.00% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of ALHRG to the average of the S&P500 Index (22.10), we can say ALHRG is valued rather cheaply.
Industry RankSector Rank
PE 2.83
Fwd PE 2.86
ALHRG.PA Price Earnings VS Forward Price EarningsALHRG.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ALHRG is valued cheaper than 100.00% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ALHRG indicates a somewhat cheap valuation: ALHRG is cheaper than 62.50% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 12.62
EV/EBITDA 2.54
ALHRG.PA Per share dataALHRG.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of ALHRG may justify a higher PE ratio.
PEG (NY)1.28
PEG (5Y)0.06
EPS Next 2Y10.34%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ALHRG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

HERIGE

EPA:ALHRG (3/7/2025, 7:00:00 PM)

23.9

-0.3 (-1.24%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)11-05 2024-11-05
Earnings (Next)03-25 2025-03-25/amc
Inst Owners1.53%
Inst Owner ChangeN/A
Ins Owners17.74%
Ins Owner ChangeN/A
Market Cap71.46M
Analysts86.67
Price Target34.68 (45.1%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend1.78
Dividend Growth(5Y)29.19%
DP22.12%
Div Incr Years1
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 2.83
Fwd PE 2.86
P/S 0.1
P/FCF 12.62
P/OCF 2.71
P/B 0.43
P/tB 0.62
EV/EBITDA 2.54
EPS(TTM)8.45
EY35.36%
EPS(NY)8.34
Fwd EY34.91%
FCF(TTM)1.89
FCFY7.92%
OCF(TTM)8.81
OCFY36.87%
SpS239.42
BVpS55.05
TBVpS38.8
PEG (NY)1.28
PEG (5Y)0.06
Profitability
Industry RankSector Rank
ROA 6.53%
ROE 14.82%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 3.41%
GM 43.42%
FCFM 0.79%
ROA(3y)3.42%
ROA(5y)2.97%
ROE(3y)12.56%
ROE(5y)10.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.95%
ROCE(5y)7.85%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-0.23%
OM growth 5Y12.98%
PM growth 3Y-14.27%
PM growth 5Y37.8%
GM growth 3Y2.69%
GM growth 5Y2.44%
F-Score8
Asset Turnover1.91
Health
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 20.35
Debt/EBITDA 3.78
Cap/Depr 65.84%
Cap/Sales 2.89%
Interest Coverage N/A
Cash Conversion 86.44%
Profit Quality 23.2%
Current Ratio 2.39
Quick Ratio 1.91
Altman-Z 3.14
F-Score8
WACC4.73%
ROIC/WACCN/A
Cap/Depr(3y)130.39%
Cap/Depr(5y)150%
Cap/Sales(3y)3.56%
Cap/Sales(5y)3.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)39.12%
EPS 3Y-4.01%
EPS 5Y47.38%
EPS Q2Q%151.61%
EPS Next Y2.21%
EPS Next 2Y10.34%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-14.27%
Revenue growth 3Y11.65%
Revenue growth 5Y6.67%
Sales Q2Q%-26.32%
Revenue Next Year3.21%
Revenue Next 2YN/A
Revenue Next 3Y-16.91%
Revenue Next 5YN/A
EBIT growth 1Y-103.11%
EBIT growth 3Y11.4%
EBIT growth 5Y20.51%
EBIT Next Year80%
EBIT Next 3Y8.97%
EBIT Next 5YN/A
FCF growth 1Y128.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y631.63%
OCF growth 3Y-23.55%
OCF growth 5Y5.66%